Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health.

By I. Ilias, D. J. Torpy, Karel Pacak, N. Mullen, R. Wesley, L. Nieman. Journal of Clinical Endocrinology and Metabolism, 2005

669 citations recorded by the source corpus.

Subfields: Education

View Paper: https://www.semanticscholar.org/paper/80a79411dd9abfc8d32f39b43a85fb927d8151da

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. F. Pacini
2. M. Schlumberger
3. Samuel A. Wells
4. Sylvia L. Asa
5. L. Nieman
6. H. Dralle
7. R. Elisei
8. B. Biller

Citations in the corpus

• Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. (2015, background): “(2 QQEE) 6.1a We suggest bilateral adrenalectomy for occult or metastatic ectopic ACTH secretion (EAS) or as a life-preserving emergency treatment in patients with very severe The Endocrine Society.”
• Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association (2009, neutral): “MTC is reported to account for up to 2–6% of all cases of ectopic Cushing syndrome (333,334).”
• Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma (2015, positive): “MTC is reported to account for up to 1%–3% of all cases of ectopic Cushing’s syndrome (361,362).”